Tilray secures new cannabis cultivation license in Germany: Is it time to buy TLRY?
Tilray Brands Inc (NASDAQ: TLRY) has made a significant stride in its European operations by securing a new cannabis cultivation license in Germany. This development, under the country’s new Cannabis Act (MedCanG), is set to substantially boost the production capacity of Tilray’s Aphria RX GmbH facility in Berlin. This news comes at a crucial time